A detailed history of Bbr Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bbr Partners, LLC holds 10,918 shares of BMY stock, worth $635,755. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,918
Previous 11,089 1.54%
Holding current value
$635,755
Previous $460,000 22.83%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $6,781 - $8,849
-171 Reduced 1.54%
10,918 $565,000
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $36,184 - $47,638
-899 Reduced 7.5%
11,089 $460,000
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $51,770 - $58,697
1,079 Added 9.89%
11,988 $650,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $21,379 - $25,511
-441 Reduced 3.89%
10,909 $559,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $20,956 - $23,432
362 Added 3.29%
11,350 $658,000
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $14,271 - $15,845
-224 Reduced 2.0%
10,988 $702,000
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $45,274 - $51,351
-689 Reduced 5.79%
11,212 $777,000
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $432 - $255,723
-3,328 Reduced 21.85%
11,901 $846,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $558,668 - $669,893
9,087 Added 147.95%
15,229 $1.11 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $98,357 - $114,661
1,834 Added 42.57%
6,142 $383,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $32,247 - $37,773
-545 Reduced 11.23%
4,308 $255,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $9,286 - $10,113
150 Added 3.19%
4,853 $324,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $76,133 - $85,627
1,283 Added 37.51%
4,703 $297,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $5,312 - $6,019
92 Added 2.76%
3,420 $212,000
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $191,127 - $211,793
3,328 New
3,328 $201,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.